Abstract We have previously reported that the majority of phospholipase A 2 (PLA 2 ) activity in rabbit ventricular myocytes is membrane-associated, calcium-independent (iPLA 2 ), selective for arachidonylated plasmalogen phospholipids and inhibited by the iPLA 2 -selective inhibitor bromoenol lactone (BEL). Here, we identified the presence of iPLA 2 in rabbit ventricular myocytes, determined the full length sequences for rabbit iPLA 2 b and iPLA 2 c and compared their homology to the human isoforms. Rabbit iPLA 2 b encoded a protein with a predicated molecular mass of 74 kDa that is 91% identical to the human iPLA 2 b short isoform. Full length iPLA 2 c protein has a predicated molecular mass of 88 kDa and is 88% identical to the human isoform. Immunoblot analysis of iPLA 2 b and c in membrane and cytosolic fractions from rabbit and human cardiac myocytes demonstrated a similar pattern of distribution with both isoforms present in the membrane fraction, but no detectable protein in the cytosol. Membrane-associated iPLA 2 activity was inhibited preferentially by the R enantiomer of bromoenol lactone [(R)-BEL], indicating that the majority of activity is due to iPLA 2 c.
Introduction
Phospholipase A 2 (PLA 2 ) catalyzes the hydrolysis of the fatty acid at the sn-2 position of membrane phospholipids, resulting in the generation of multiple biologically-active, membrane phospholipid-derived metabolites (for review, see [1] ). The family of PLA 2 enzymes has been classified into 15 groups and several subgroups based on the catalytic mechanism, functional and structural features, and sequence homology [1] .
We reported previously that the majority of PLA 2 activity in rabbit ventricular myocytes is membrane-associated, calcium-independent (iPLA 2 ) and selective for arachidonylated plasmalogen phospholipids [2] . Activation of this membrane-associated iPLA 2 occurs when ventricular myocytes are incubated with phorbol 12-myristate 13-acetate, suggesting that activation of iPLA 2 is regulated by protein kinase C [3] . We have also demonstrated that rabbit ventricular myocyte membrane-associated iPLA 2 is activated in response to either thrombin stimulation [4] or the presence of hypoxia [5] . Multiple types of iPLA 2 have been identified in cytosolic, microsomal and mitochondrial fractions from mammalian myocardium [6, 7] , but to date there is no data concerning the specific iPLA 2 isoform that may be present and activated in rabbit ventricular myocytes. Our previous data indicate that rabbit ventricular myocyte iPLA 2 activity is inhibited by bromoenol lactone (BEL) but not by methyl arachidonyl fluorophosphonate (MAFP) [2] , suggesting that it is either iPLA 2 b or iPLA 2 c.
The iPLA 2 b isoform is predominantly a cytosolic isoform and highly homologous cDNAs have been cloned from the hamster, mouse, rat and human (approximately 95% identity). In addition, several splice variants of human iPLA 2 b have been identified [8] . However, in COS-7 cells overexpressing iPLA 2 b, Larsson Forsell et al demonstrated a 5.5-fold increase in membrane-associated iPLA 2 activity [8] , and membrane-associated iPLA 2 b has also been found in rat vascular smooth muscle cells [9] .
More recently, a novel membrane associated iPLA 2 (iPLA 2 c) has been identified [7] which possesses several of the properties demonstrated in our previous studies using rabbit ventricular myocytes, including the optimum pH for activity, sensitivity to BEL and a tight association with the membrane fraction. Homology between iPLA 2 b and iPLA 2 c is confined to the ATP binding motif, the serine lipase site and a region of nine amino acids for which, as yet, there is no known functional significance [7] . The human iPLA 2 c gene contains 4 possible translation codons that result in proteins of 63, 74, 77 and 88 kDa [10] . When first described, iPLA 2 c was proposed to be localized to peroxisomes due to the presence of a C-terminal SKL signal sequence and recent studies have confirmed that the peroxisomal iPLA 2 c is the 63-kDa protein [11] . More recent studies have demonstrated higher molecular weight isoforms of iPLA 2 c in mitochondria and endoplasmic reticulum [6] .
This study was designed to identify the presence of iPLA 2 b and iPLA 2 c in rabbit ventricular myocytes and to determine the similarity of these isoforms to those identified previously.
Experimental Procedures
Rabbit Ventricular Myocyte Isolation and Culture Adult rabbits of either sex weighing 2-3 kg were anesthetized with intravenous pentobarbitone sodium (50 mg/ kg) and the heart rapidly removed. The heart was mounted on a Langendorff perfusion apparatus and perfused for 5 min with a Tyrode solution containing (mmol/l) NaCl 118, KCl 4.8, CaCl 2 1.2, MgCl 2 1.2, NaHCO 3 24, KH 2 PO 4 1.2 and glucose 11; the Tyrode solution was saturated with 95%O 2 /5%CO 2 to yield a pH of 7.4. This was followed by a 4-min perfusion with a Ca-free Tyrode solution containing EGTA (100 lM) and a final perfusion for 20 min with the Tyrode solution containing 100 lM Ca and 0.033% collagenase. The heart was removed from the perfusion apparatus, the atria were removed and the remaining ventricles were cut into small pieces and incubated in fresh 0.033% collagenase solution at 37°C in a shaking water bath for 4 successive harvests of 20 min. 
Culture of Human Cardiac Myocytes
Human adult cardiac myocytes (Sciencell, San Diego, CA) were cultured in cardiac myocyte medium consisting of 500 ml of basal medium, 25 ml of fetal bovine serum, 5 ml of cardiac myocyte growth supplement and 5 ml of penicillin/streptomycin solution (Sciencell, San Diego, CA).
Generation of iPLA 2 Clones
Total RNA for use in all cloning steps was isolated with the Versagene Cell Kit (Gentra Systems, Minneapolis, MN); 5 0 and 3 0 end sequences of rabbit ventricular myocyte iPLA 2 were obtained by rapid amplification of cDNA ends following the manufacturer's instructions for the GeneRacer Kit from Invitrogen (Carlsbad, CA). Briefly, total RNA was dephosphorylated, decapped and ligated to the GeneRacer RNA Oligo to form template for first strand RACEready cDNA synthesis. Following cDNA amplification with the appropriate GeneRacer Oligo and gene specific Oligo, 5 0 and 3 0 end PCR fragments were cloned into the pCR4-TOPO vector and sequenced by automated DNA sequencing with BigDye chemistry. This sequence was conceptually translated and Oligos were designed to yield a full-length amplicon corresponding to the longest open reading frame for each isoform. Oligo dT primed first strand cDNA was generated from total RNA using the Thermoscript RT-PCR System (Invitrogen) and used as template for PCR amplification of full-length iPLA 2 clones. These products were cloned into the pCR-XL-TOPO vector and five independent clones of each isoform, b and c, were sequenced. Sequence analysis and assembly was performed using the Vector NTI Suite 9.0.0 (Invitrogen) and the BLAST server at NCBI. Sequence assembly was performed using the ContigExpress program (Invitrogen) and the full-length cDNA sequences were deposited into Genbank (iPLA 2 b-Accession # AY744674, iPLA 2 c-Accession # AY738591).
Production of iPLA 2 c Antibody A custom-made chicken antibody was obtained from Aves Labs, Inc. (Tigard, OR). Hens were injected four times with a KLH conjugate of the peptide CZSKYIERNEHKMK KVAK and immune eggs were collected for 10-15 days after the final injection. The IgY fractions were purified and passed over an affinity column, the column washed and antibody eluted. The final concentration of affinity-purified antibody in the eluant was 0.6 mg/ml.
HPLC Separation of (R)-and (S)-Enantiomers of BEL
(R)-and (S)-enantiomers of BEL were isolated from racemic BEL (Calbiochem) using a chirex 3,5-dinitrobenzoyl-(R)-phenylglycine chiral HPLC column (Phenomenex Inc., Torrance, CA) and previously published methods [17] . The column was equilibrated with hexane/dichloroethane/ethanol (150:15:1, by vol) and the optical enantiomers eluted isocratically at 2 ml/min. Elution of (R)-and (S)-BEL was monitored by UV absorbance at 280 nm. Under these conditions the retention times (R t ) for (R)-and (S)-BEL differ by almost 1 min with the R t for (S)-BEL being 11.1 min and 12.2 min for (R)-BEL [12] . Peaks corresponding to these R t were collected, dried under N 2 , and stored at -20°C. The concentration of each enantiomer was determined spectrophotometrically based on its UV absorbance [12] .
Immunoblot Analysis of iPLA 2 Isoforms
Myocytes were suspended in lysis buffer containing (mmol/l) HEPES 20 (pH 7.6), sucrose 250, dithiothreitol 2, EDTA 2, EGTA 2, b-glycerophosphate 10, sodium orthovanadate 1, phenylmethylsulfonyl fluoride 2, leupeptin 20 lg/ml, aprotinin 10 lg/ml and pepstatin A 5 lg/ml (buffer 2). Cells were sonicated on ice for 6 bursts of 10 s and centrifuged at 10,0009g at 4°C for 20 min to remove cellular debris and nuclei. Cytosolic and membrane fractions were separated by centrifuging the supernatant at 100,0009g for 60 min. The pellet was resuspended in lysis buffer and the suspension centrifuged at 100,0009g for 60 min twice to minimize contamination of the membrane fraction with cytosolic protein. The final pellet was resuspended in lysis buffer containing 0.1% Triton X-100. Protein (cytosol or membrane) was mixed with an equal volume of SDS sample buffer and heated at 95°C for 5 min prior to loading onto a 10% polyacrylamide gel. Protein was separated by SDS/PAGE at 200 V for 35 min and electrophoretically transferred to PVDF membranes (Bio-Rad, Richmond, CA) at 100 V for 1 h. Non-specific sites were blocked with Tris buffered solution containing 0.05% (v/v) Tween-20 (TBST) and 5% (w/v) nonfat milk for 1 h at room temperature. The blocked PVDF membrane was incubated with primary antibodies to iPLA 2 b (1 in 1,000 dilution, Cayman Chemical Company, Ann Arbor, MI) or iPLA 2 c (1 in 1,000 dilution, Aves Labs Inc., Tigard, OR), followed by horseradish peroxidase-conjugated secondary antibodies. Regions of antibody binding were detected using enhanced chemiluminescence (Amersham, Arlington Heights, IL) after exposure to film (Hyperfilm, Amersham). Multiple exposures of film to the blots were developed.
Phospholipase A 2 Activity Myocytes were suspended in 1 ml buffer containing (mmol/l): Sucrose 250, KCl 10, imidazole 10, EDTA 5, dithiothreitol (DTT) 2 with 10% glycerol, pH 7.8 (buffer 1). The suspension was sonicated on ice six times for 10 s (using a microtip probe at 20% power output, 500 Sonic Dismembrator, Fisher Scientific) and the sonicate centrifuged at 20,0009g for 20 min to remove cellular debris and nuclei. The supernatant was then centrifuged at 100,0009g for 60 min to separate the membrane fraction (pellet) from the cytosolic fraction (supernatant). The pellet was washed twice to minimize contamination of the membrane fraction with cytosolic protein by resuspending in buffer1, and centrifuging at 100,0009g for 60 min. The final pellet was resuspended in buffer 1. PLA 2 activity in cytosolic and membrane fractions was assessed by incubating enzyme (8 lg membrane protein) with 100 lM (16:0, [ 3 H]18:1) plasmenylcholine substrate in assay buffer containing (mmol/l): Tris 10, EGTA 4, 10% glycerol, pH 7.0 at 37°C for 5 min in a total volume of 200 ll. The radiolabeled phospholipid substrate was introduced into the incubation mixture by injection in 5 ll ethanol to initiate the assay. Reactions were terminated by the addition of 100 ll butanol and released radiolabeled fatty acid was isolated by application of 25 ll of the butanol phase to channeled Silica Gel G plates, development in petroleum ether/diethyl ether/acetic acid (70/30/1, v/v) and subsequent quantification by liquid scintillation spectrometry. Protein content of each sample was determined by the Lowry method utilizing freeze dried bovine serum albumin as the protein standard. Radiolabeled (16:0, [ 3 H]18:1) plasmenylcholine was synthesized using [9,10- 3 H] oleic acid and lysoplasmenylcholine as described in detail previously [4] .
Statistical Analysis
Statistical comparison of values was performed by Student's t test. All results are expressed as mean ± SEM. Statistical significance was considered to be P \ 0.05. determined (Fig. 1) . The longest open reading frame of iPLA 2 b was found to encode a protein of 665 amino acids in length with a predicted molecular mass of 74 kDa that a BLAST analysis of the non-redundant protein database reveals is 91% identical to the human short isoform. The sequences are highly conserved except for a divergent segment at the N-terminus which is 128 amino acids long in the human and 42 amino acids in the rabbit. Immunoblot analysis of cytosolic and membrane fractions isolated from rabbit and human cardiac myocytes demonstrated an Fig. 1 Full-length rabbit iPLA2b cDNA sequence.
Underlines indicate the conserved ATP-binding and lipase active sites. Potential transmembrane domains were predicted using the TMpred server and are indicated with boldface type. Potential PKCphosphorylation sites were predicted using the NetPhosK 1.0 Server and are boxed iPLA 2 b immunoreactive band that ran just below the 80-kDa molecular mass marker (Fig. 3a) . The human and rabbit immunoreactive bands ran at a similar molecular weight and were present in the membrane fraction only. No immunoreactive band was detected with iPLA 2 b antibody in the cytosolic fraction of human or rabbit myocytes (Fig. 3a) . Rabbit ventricular myocyte iPLA 2 c was also cloned and sequenced, and is predicted to encode a full-length protein of 786 amino acids (Fig. 2) with a molecular mass of 88 kDa that was found by BLAST analysis to be 88% identical to the human form. It has been reported previously that the human iPLA 2 c sequence contains multiple alternative start sites for translation, which correspond to protein products of 88, 77, 74 and 63 kDa [10] . We analyzed the amino acid sequence for iPLA 2 c in rabbit ventricular myocytes and identified 6 methionine residues upstream of the active site which could encode functional PLA 2 . In addition to the 88-, 77-, 74-, and 63-kDa isoforms found in the human isoform, we also identified two single amino acid substitutions which could encode alternative start sites for 58 and 49 kDa proteins. Immunoblot analysis of rabbit ventricular myocytes detected immunoreactive bands corresponding to the 88-and 73-kDa isoenzymes in the membrane fraction of isolated rabbit ventricular myocytes. Immunoblot analysis of human cardiac myocytes revealed a single band corresponding to the 73-kDa isoform of iPLA 2 c in the membrane fraction (Fig. 3b) . No bands were detected in the cytosolic fractions from either rabbit or human myocytes (Fig. 3b) .
Since we detected both iPLA 2 b and c in isolated rabbit ventricular myocytes and the majority of iPLA 2 activity is membrane-associated, we incubated isolated membrane fractions with (R)-BEL, (S)-BEL or racemic BEL. Previous studies have indicated that (S)-BEL is approximately an order of magnitude more selective for iPLA 2 b in . After pretreatment with BEL for 10 min, membrane-associated iPLA 2 activity was significantly decreased with concentrations of (R)-BEL greater than 0.1 lM (Fig. 4) . At 10 lM, (R)-BEL inhibited iPLA 2 activity by 90%, whereas (S)-BEL inhibited iPLA 2 activity by approximately 50% (Fig. 4) .
Discussion
Myocardial iPLA 2 activity in the rabbit was first described by Ford et al. [13] . They described a tenfold increase in microsomal, plasmalogen-selective iPLA 2 activity during myocardial ischemia [13] . We have demonstrated increases in membrane-associated, plasmalogen-selective iPLA 2 activity in isolated rabbit ventricular myocytes in response to thrombin [14] and hypoxia [5] . The activation of iPLA 2 and accelerated plasmalogen phospholipid hydrolysis lead to the production of lysoplasmenylcholine [5, 14] , an amphipathic metabolite that can have direct effects on the function of integral membrane proteins. We have shown that lysoplasmenylcholine produces action potential derangements in cardiac myocytes at much lower concentrations than that previously demonstrated for lysoplasmenylcholine [5] . The action potential derangements caused by lysoplasmenylcholine occur as a result of its action on multiple membrane currents [15] . Although several studies have described iPLA 2 activation in rabbit ventricular myocytes, this is the first study to sequence iPLA 2 b and iPLA 2 c and to demonstrate that iPLA 2 c is the major isoform in the rabbit myocardium. Our immunoblot analysis data suggest that the vast majority of iPLA 2 is membrane-associated, and this agrees with our previous data measuring iPLA 2 activity [2] . In previously reported studies, iPLA 2 b has been demonstrated to be primarily cytosolic. It was originally purified from the cytosol of the mouse macrophage cell line P388D 1 [16] and its cDNA was later identified in P388D 1 and Chinese hamster ovary cells [17] and human B lymphocytes [18] . In humans the difference between the membrane-associated and cytosolic isoforms is the presence of 54 amino acid residues that may lead to a membrane-associated protein [8] . While we did not identify a similar sequence in the rabbit isoform, TMpred analysis suggests that rabbit iPLA 2 b contains a potential transmembrane domain (indicated by the boldface type in Fig. 1) .
In a previous study, we have identified the presence of multiple iPLA 2 isoforms in several tissues and species [6] . The role of myocardial iPLA 2 isoforms has been investigated in several recent studies using mouse models. iPLA 2 activity in murine heart is less than 5% of that in human myocardium, suggesting that the mouse could be a speciesspecific knockdown model of human ischemia-induced arrhythmogenesis [19] . Accordingly, Mancuso et al. [19] generated transgenic mice that expressed amounts of Values are mean ± SEM for independent results from six separate animals. *P \ 0.05, **P \ 0.01 when compared to activity in the absence of BEL iPLA 2 b activity comparable to that present in human myocardium and demonstrated malignant ventricular arrhythmias, increased fatty acid release in venous effluents and increased lysophospholipid content in the ischemic zone in response to ischemia. These data demonstrate the role of myocardial iPLA 2 b in the hydrolysis of membrane phospholipids and arryhthmogenesis in response to ischemia. Transgenic mice expressing iPLA 2 c in cardiac myocytes demonstrated a marked loss of mitochondrial phospholipids accompanied by mitochondrial dysfunction [20] . In a subsequent study, mice null for iPLA 2 c displayed growth retardation, cold intolerance, reduced exercise endurance and abnormal mitochondrial function [21] . In particular, iPLA 2 c knockout mice were more susceptible to sudden death following transverse aortic constriction, indicating the importance of iPLA 2 c in the ability of the myocardium to respond to stress [21] .
We have previously reported that incubation of isolated membrane fractions from rabbit ventricular myocytes demonstrate increased iPLA 2 activity when incubated with phorbol 12-myristate 13-acetate in the absence of Ca [3] . These data suggests that a membraneassociated novel PKC isoform modulates iPLA 2 activity. Increased iPLA 2 activity required the presence of ATP, suggesting that the enzyme is phosphorylated by PKC [3] . Sequence analysis of rabbit ventricular myocyte iPLA 2 band c isoforms reveals the presence of several predicted PKC phosphorylation sites that are indicated by the boxes in Figs. 1 and 3 .
In conclusion, we have identified and sequenced iPLA 2 band iPLA 2 c from isolated rabbit ventricular myocytes. These isoforms possess a high degree of sequence homology between rabbit and human and there is a similar protein expression pattern when comparing rabbit and human cardiac myocytes. Both isoforms have several putative PKC phosphorylation sites and our previous studies suggest that membrane-associated iPLA 2 is activated directly by a membrane-associated novel PKC isoform [3] . Finally, our data obtained using (R)-and (S)-enantiomers of the iPLA 2 -selective inhibitor BEL, suggest that the majority of membrane-associated iPLA 2 activity is iPLA 2 c.
